Colon Cancer
Key Points
- Colon cancer (including rectal involvement) is a major cause of cancer mortality and often progresses silently in early stages.
- Risk increases with family history, prior polyps, inflammatory bowel disease, abdominal radiation exposure, obesity, tobacco/alcohol use, and high red/processed meat intake.
- Screening and early detection commonly occur through stool-based tests and colonoscopy pathways.
- Definitive diagnosis requires colonoscopy with biopsy; CEA is used for treatment monitoring rather than primary diagnosis.
- Treatment may include surgery, chemotherapy, immunotherapy/biologics, and in extensive disease, colectomy with colostomy.
Pathophysiology
Colon cancer develops through accumulated genetic mutations that transform normal colonic epithelium into malignant tissue. Disease extent is commonly described with the TNM framework (primary tumor, nodal spread, distant metastasis). Common metastatic targets include liver, lungs, and lymphatic structures.
Classification
- Screen-detected disease: Found incidentally during routine stool screening or colonoscopy.
- Symptom-detected disease: Presentation with blood in stool, abdominal pain, anemia, or bowel-habit change.
- Localized vs metastatic disease: Determines whether management is surgery-first, systemic therapy, or multimodal treatment.
Nursing Assessment
NCLEX Focus
A positive stool-based screening test requires timely colonoscopic follow-up; delay can miss a treatable cancer window.
- Assess risk profile: family history, prior polyps, IBD history, lifestyle factors, and prior radiation.
- Assess symptom cues: hematochezia/occult blood, abdominal pain, bowel-pattern change, anemia-related fatigue.
- Assess screening-interval status (routine ages 45-75; individualized decisions ages 76-85) and whether any prior stool-based test required colonoscopic follow-up.
- Track diagnostic pathway:
- Stool-based screening (including DNA/occult blood panels) as entry points
- Colonoscopy with biopsy for definitive diagnosis
- Imaging support (barium enema, CT, MRI) for disease mapping when indicated
- CEA trend for treatment-response and recurrence monitoring, not stand-alone diagnosis
- Monitor for metastatic symptom patterns (hepatic, pulmonary, nodal involvement).
Nursing Interventions
- Coordinate expedited diagnostic follow-up after abnormal screening.
- Reinforce bowel-prep and sedation safety education for colonoscopy workflows.
- Provide perioperative teaching for surgical candidates, including potential ostomy outcomes.
- Support chemotherapy/immunotherapy symptom monitoring and adherence planning.
- Teach red-flag escalation: ongoing bleeding, obstructive symptoms, severe pain, fever, or rapid functional decline.
- Provide psychosocial support and survivorship-planning resources.
Screening Follow-Through
Stool or blood-based screening alone does not confirm or exclude cancer without appropriate diagnostic completion.
Pharmacology
| Category | Examples | Nursing considerations |
|---|---|---|
| Systemic anticancer therapy | Chemotherapy and immunotherapy/biologic protocols | Monitor for cytopenias, infection risk, GI toxicity, and treatment adherence |
| Symptom and supportive medications | Antiemetics, pain regimens, bowel-support agents | Tailor to treatment phase and bowel-function changes |
Clinical Judgment Application
Clinical Scenario
A 57-year-old with a positive stool DNA screening result reports intermittent blood in stool and fatigue.
- Recognize Cues: High-risk screen plus compatible symptom pattern.
- Analyze Cues: Malignancy must be ruled in/out with definitive tissue diagnosis.
- Prioritize Hypotheses: Priority is rapid diagnostic completion and staging.
- Generate Solutions: Arrange colonoscopy/biopsy pathway, baseline labs, and education for next steps.
- Take Action: Coordinate testing and reinforce follow-up reliability.
- Evaluate Outcomes: Diagnosis and stage are established without delay, enabling timely treatment planning.
Related Concepts
- colonoscopy-preparation-and-follow-up - Definitive diagnostic and surveillance pathway.
- stool-tests-for-bowel-function-evaluation - Screening tools that trigger colonoscopy when positive.
- inflammatory-bowel-disease - Chronic IBD increases colorectal malignancy risk over time.
- colostomy-care - Post-colectomy bowel-diversion care when ostomy is required.
- adult-preventive-screening-and-health-promotion - Population-level prevention and follow-up coordination.
Self-Check
- Why is CEA not sufficient as a stand-alone diagnostic test for colon cancer?
- Which risk factors should trigger heightened vigilance for colorectal malignancy?
- What nursing actions reduce delay after a positive stool-based screen?